Scholars@Duke
Journal cover image

A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.

Publication ,  Journal Article
Hotchkiss, KM; Cho, EJ; Khasraw, M
Published in: Neuro Oncol
January 5, 2024
Published version (DOI) Link to item

Duke Scholars

Mustafa Khasraw
Author Mustafa Khasraw Neurosurgery

Published In

Neuro Oncol

DOI

10.1093/neuonc/noad203

EISSN

1523-5866

Publication Date

January 5, 2024

Volume

26

Issue

1

Start / End Page

5 / 6

Location

England

Related Subject Headings

  • Protein Subunit Vaccines
  • Oncology & Carcinogenesis
  • Mutation
  • Humans
  • Glioma
  • Brain Neoplasms
  • Adult
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hotchkiss, K. M., Cho, E. J., & Khasraw, M. (2024). A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma. Neuro Oncol, 26(1), 5–6. https://doi.org/10.1093/neuonc/noad203
Hotchkiss, Kelly M., Eugene J. Cho, and Mustafa Khasraw. “A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.” Neuro Oncol 26, no. 1 (January 5, 2024): 5–6. https://doi.org/10.1093/neuonc/noad203.
Hotchkiss, Kelly M., et al. “A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.” Neuro Oncol, vol. 26, no. 1, Jan. 2024, pp. 5–6. Pubmed, doi:10.1093/neuonc/noad203.
Journal cover image

Published In

Neuro Oncol

DOI

10.1093/neuonc/noad203

EISSN

1523-5866

Publication Date

January 5, 2024

Volume

26

Issue

1

Start / End Page

5 / 6

Location

England

Related Subject Headings

  • Protein Subunit Vaccines
  • Oncology & Carcinogenesis
  • Mutation
  • Humans
  • Glioma
  • Brain Neoplasms
  • Adult
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences